Top Abstract Purchase Related
Home
>
Node
>
Subnode

Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission

Flys, T.S.; McConnell, M.S.; Matovu, F.; Church, J.D.; Bagenda, D.; Khaki, L.; Bakaki, P.; Thigpen, M.C.; Eure, C.; Fowler, M.Glenn.; Eshleman, S.H.

Journal of Infectious Diseases 198(4): 465-469

2008

ISSN/ISBN: 0022-1899
PMID: 18582198
DOI: 10.1086/590160
Document Number: 201984
Single-dose (SD) nevirapine (NVP) significantly reduces mother-to-child transmission of human immunodeficiency virus (HIV). We analyzed NVP resistance after receipt of SD NVP in 57 previously SD NVP-naive women, in 34 SD NVP-experienced women, and in 17 HIV-infected infants. The proportion of women infected with variants with resistance mutations, the types of mutations detected, and the frequency and level of K103N were similar in the two groups of women at 6 weeks and 6 months post partum. NVP resistance was detected in a similar proportion of infants born to SD NVP-naive versus SD NVP-experienced women. Repeated use of SD NVP to prevent HIV transmission does not appear to influence NVP resistance.

Document emailed within 0-6 h
Secure & encrypted payments

Chantarangsu, S.; Cressey, T.R.; Mahasirimongkol, S.; Capparelli, E.; Tawon, Y.; Ngo-Giang-Huong, N.; Jourdain, G.; Lallemant, M.; Chantratita, W. 2009: Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women Journal of Antimicrobial ChemoTherapy 64(6): 1265-1273
Delvaux, Térèse.; Elul, B.; Ndagije, F.; Munyana, E.; Roberfroid, D.; Asiimwe, A. 2009: Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda Journal of Acquired Immune Deficiency Syndromes 50(2): 223-230
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Bii, S.C.; Otieno-Nyunya, B.; Siika, A.; Rotich, J.K. 2007: Self-reported adherence to single dose nevirapine in the prevention of mother to child transmission of HIV at Kitale District Hospital East African Medical Journal 84(12): 571-576
Walter, J.; Kuhn, L.; Kankasa, C.; Semrau, K.; Sinkala, M.; Thea, D.M.; Aldrovandi, G.M. 2008: Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study Bmc Infectious Diseases 8: 172
Jacob, M.S.; Durairaj, A.; Vijayakumari, J.; Srijayanth, P.; Sivakumar, M.R. 2011: Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India Indian Journal of Pathology and Microbiology 54(2): 359-361
Peltzer, K.; Mlambo, M.; Phaswana-Mafuya, N.; Ladzani, R. 2010: Determinants of adherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Gert Sibande district in South Africa Acta Paediatrica 99(5): 699-704
Tsague, L.; Tsiouris, F.Oliveira.; Carter, R.J.; Mugisha, V.; Tene, G.; Nyankesha, E.; Koblavi-Deme, S.; Mugwaneza, P.; Kayirangwa, E.; Sahabo, R.; Abrams, E.J. 2010: Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens Bmc Public Health 10: 753
Barigye, H.; Levin, J.; Maher, D.; Tindiwegi, G.; Atuhumuza, E.; Nakibinge, S.; Grosskurth, H. 2010: Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting Tropical Medicine and International Health: Tm and Ih 15(10): 1163-1171
Eshleman, S.H.; Jackson, J.B. 2002: Nevirapine resistance after single dose prophylaxis Aids Reviews 4(2): 59-63
Stringer, J.S.A.; Sinkala, M.; Chapman, V.; Acosta, E.P.; Aldrovandi, G.M.; Mudenda, V.; Stout, J.P.; Goldenberg, R.L.; Kumwenda, R.; Vermund, S.H. 2003: Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine Aids 17(11): 1659-1665
de Vincenzi, I.; Farley, T.; Gaillard, P.; Meda, N.; Rollins, N.; Luchters, S.; Nduati, R.; Newell, M-Louise.; Read, J.; Dioulasso, B.; Faso, B.; Meda, N.; Fao, P.; Ky-Zerbo, O.; Gouem, C.; Somda, P.; Hien, Hé.; Ouedraogo, P.Elysée.; Kania, D.; Sanou, A.; Kossiwavi, I.Ayassou.; Sanogo, B.; Ouedraogo, M.; Siribie, I.; Valéa, D.; Ouedraogo, S.; Somé, R.; Rouet, Fçois.; Rollins, N.; McFetridge, L.; Naidu, K.; Luchters, S.; Reyners, M.; Irungu, E.; Katingima, C.; Mwaura, M.; Ouattara, G.; Mandaliya, K.; Wambua, S.; Thiongo, M.; Nduati, R.; Kose, J 2011: Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial Lancet. Infectious Diseases 11(3): 171-180
Jørgensen, L.B.; Katzenstein, T.L.; Gerstoft, J.; Mathiesen, L.R.; Pedersen, C.; Nielsen, C. 2000: Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine Antiviral Therapy 5(3): 187-194
Manosuthi, W.; Kiertiburanakul, S.; Chaovavanich, A.; Sungkanuparph, S. 2007: Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients Journal of the Medical Association of Thailand 90(2): 244-250
Bedri, A.; Gudetta, B.; Isehak, A.; Kumbi, S.; Lulseged, S.; Mengistu, Y.; Bhore, A.V.; Bhosale, R.; Varadhrajan, V.; Gupte, N.; Sastry, J.; Suryavanshi, N.; Tripathy, S.; Mmiro, F.; Mubiru, M.; Onyango, C.; Taylor, A.; Musoke, P.; Nakabiito, C.; Abashawl, A.; Adamu, R.; Antelman, G.; Bollinger, R.C.; Bright, P.; Chaudhary, M.A.; Coberly, J.; Guay, L.; Fowler, M.Glenn.; Gupta, A.; Hassen, E.; Jackson, J.Brooks.; Moulton, L.H.; Nayak, U.; Omer, S.B.; Propper, L.; Ram, M.; Rexroad, V.; Ruff, A.J.; Shankar, A.; Zwerski, S.; Abate, 2008: Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials Lancet 372(9635): 300-313
Rajesh, L.; Ramesh, K.; Hanna, L.E.; Narayanan, P.R.; Swaminathan, S. 2010: Emergence of drug resistant mutations after single dose nevirapine exposure in HIV-1 infected pregnant women in south India Indian Journal of Medical Research 132: 509-512
Rajesh, L.; Ramesh, K.; Hanna, L.E.; Narayanan, P.R.; Swaminathan, S. 2010: Emergence of drug resistant mutations after single dose nevirapine exposure in HIV-1 infected pregnant women in south India Indian Journal of Medical Research 132: 509-512
Baleta, A. 2003: South African government threatens to ban nevirapine. Move would take away option for treating vertical HIV transmission Lancet 362(9382): 451
Pilger, D.; Hauser, A.; Kuecherer, C.; Mugenyi, K.; Kabasinguzi, R.; Somogyi, S.; Harms, G.; Kunz, A. 2011: Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis Antiviral Therapy 16(1): 109-113
Dorenbaum, A.; Cunningham, C.K.; Gelber, R.D.; Culnane, M.; Mofenson, L.; Britto, P.; Rekacewicz, C.; Newell, M-Louise.; Delfraissy, J.Francois.; Cunningham-Schrader, B.; Mirochnick, M.; Sullivan, J.L. 2002: Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial JAMA 288(2): 189-198